Search Results

There are 3788 results for: content related to: Practical use of hepatitis C virus kinetics monitoring in the treatment of chronic hepatitis C

  1. You have free access to this content
    Rapid virological response and treatment duration for chronic hepatitis C genotype 1 patients: A randomized trial

    Hepatology

    Volume 47, Issue 6, June 2008, Pages: 1884–1893, Ming-Lung Yu, Chia-Yen Dai, Jee-Fu Huang, Chang-Fu Chiu, Yi-Hsin C. Yang, Nai-Jen Hou, Li-Po Lee, Ming-Yen Hsieh, Zu-Yau Lin, Shinn-Cherng Chen, Ming-Yuh Hsieh, Liang-Yen Wang, Wen-Yu Chang and Wan-Long Chuang

    Article first published online : 28 MAY 2008, DOI: 10.1002/hep.22319

  2. Plasma HCV-RNA decline in the first 48 h identifies hepatitis C virus mono-infected but not HCV/HIV-coinfected patients with an undetectable HCV viral load at week 4 of peginterferon-alfa-2a/ribavirin therapy

    Journal of Viral Hepatitis

    Volume 16, Issue 12, December 2009, Pages: 867–875, J. E. Arends, J. Cohen Stuart, L. C. Baak, M. E. Van Der Ende, K. J. Van Erpecum, C. P. M. Simons, G. J. Boland, D. Van Baarle and A. I. M. Hoepelman

    Article first published online : 11 MAY 2009, DOI: 10.1111/j.1365-2893.2009.01143.x

  3. Individualisation of antiviral therapy for chronic hepatitis C

    Journal of Gastroenterology and Hepatology

    Volume 25, Issue 7, July 2010, Pages: 1206–1216, Narci C Teoh, Geoffrey C Farrell and Henry L-Y Chan

    Article first published online : 24 MAY 2010, DOI: 10.1111/j.1440-1746.2010.06392.x

  4. You have free access to this content
    HCV Therapeutics: Approved Agents

    Hepatology

    Volume 58, Issue S1, October 2013, Pages: 1091A–1168A,

    Article first published online : 15 OCT 2013, DOI: 10.1002/hep.26880

  5. You have free access to this content
    Implications of rapid virological response in hepatitis C therapy in the US veteran population

    Alimentary Pharmacology & Therapeutics

    Volume 35, Issue 1, January 2012, Pages: 105–115, E. W. Hwang, I.-C. Thomas, R. Cheung and L. I. Backus

    Article first published online : 7 NOV 2011, DOI: 10.1111/j.1365-2036.2011.04903.x

  6. You have free access to this content
    Efficacy and safety of peginterferon alfa-2a (40KD) plus ribavirin in hepatitis C patients with advanced fibrosis and cirrhosis

    Hepatology

    Volume 51, Issue 2, February 2010, Pages: 388–397, Savino Bruno, Mitchell L. Shiffman, Stuart K. Roberts, Edward J. Gane, Diethelm Messinger, Stephanos J. Hadziyannis and Patrick Marcellin

    Article first published online : 29 SEP 2009, DOI: 10.1002/hep.23340

  7. You have free access to this content
    Review article: the role of rapid virological response in determining treatment duration for chronic hepatitis C

    Alimentary Pharmacology & Therapeutics

    Volume 31, Issue 12, June 2010, Pages: 1251–1267, F. F. POORDAD

    Article first published online : 17 MAR 2010, DOI: 10.1111/j.1365-2036.2010.04300.x

  8. Early identification of achieving a sustained virological response in chronic hepatitis C patients without a rapid virological response

    Journal of Gastroenterology and Hepatology

    Volume 25, Issue 4, April 2010, Pages: 758–765, Chung-Feng Huang, Jeng-Fu Yang, Jee-Fu Huang, Chia-Yen Dai, Chang-Fu Chiu, Nai-Jen Hou, Ming-Yen Hsieh, Zu-Yau Lin, Shinn-Cherng Chen, Ming-Yuh Hsieh, Liang-Yen Wang, Wen-Yu Chang, Wan-Long Chuang and Ming-Lung Yu

    Article first published online : 14 OCT 2009, DOI: 10.1111/j.1440-1746.2009.06148.x

  9. You have free access to this content
    Poster Session 2: Hepatitis C: Approved Therapeutic Agents

    Hepatology

    Volume 60, Issue S1, October 2014, Pages: 659A–709A,

    Article first published online : 1 OCT 2014, DOI: 10.1002/hep.27516

  10. You have full text access to this OnlineOpen article
    Factors associated with rapid and early virologic response to peginterferon alfa-2a/ribavirin treatment in HCV genotype 1 patients representative of the general chronic hepatitis C population

    Journal of Viral Hepatitis

    Volume 17, Issue 2, February 2010, Pages: 139–147, M. Rodriguez-Torres, M. S. Sulkowski, R. T. Chung, F. M. Hamzeh and D. M. Jensen

    Article first published online : 5 AUG 2009, DOI: 10.1111/j.1365-2893.2009.01157.x

  11. Pegylated interferon plus optimized weight-based ribavirin dosing negate the influence of weight and body mass index on early viral kinetics and sustained virological response in chronic hepatitis C

    Journal of Viral Hepatitis

    Volume 17, Issue 12, December 2010, Pages: 834–838, V. Pattullo, N. C. Ravindran, T. Mazzulli, D. K. H. Wong and E. J. Heathcote

    Article first published online : 10 NOV 2010, DOI: 10.1111/j.1365-2893.2010.01248.x

  12. Value of interleukin-28B genetic polymorphism on retreatment outcomes of chronic hepatitis C genotype 1 relapsers by peginterferon alfa plus ribavirin

    Journal of Gastroenterology and Hepatology

    Volume 29, Issue 1, January 2014, Pages: 102–109, Ming-Yao Chen, Chen-Hua Liu, Ting-Chih Chen, Tung-Hung Su, Pei-Jer Chen, Ding-Shinn Chen, Jia-Horng Kao and Chun-Jen Liu

    Article first published online : 19 DEC 2013, DOI: 10.1111/jgh.12329

  13. Response-guided peginterferon-alpha-2b plus ribavirin therapy for chronic hepatitis C patients with genotype 2 and high viral loads

    Hepatology Research

    Volume 42, Issue 9, September 2012, Pages: 854–863, Ken Sato, Hiroaki Hashizume, Yuichi Yamazaki, Norio Horiguchi, Satoru Kakizaki, Hitoshi Takagi, Masatomo Mori and the Gunma Liver Study Group

    Article first published online : 4 APR 2012, DOI: 10.1111/j.1872-034X.2012.00997.x

  14. In routine clinical practice, few physicians use early viral kinetics to guide HCV dual therapy treatment decisions

    Liver International

    Volume 34, Issue 7, August 2014, Pages: e217–e228, Alessandra Mangia, Tivadar Bányai, Giuseppe De Bartolomeo, Judit Gervain, François Habersetzer, Jean-Pierre Mulkay, Denis Ouzan, Giustino Parruti, Nicola Passariello, Andre-Jean Remy, Mario Rizzetto, Mitchell L. Shiffman, Alan D. Tice, Manuela Schmitz, Fernando Tatsch and Maribel Rodriguez-Torres

    Article first published online : 20 NOV 2013, DOI: 10.1111/liv.12352

  15. You have free access to this content
    Limited use of interleukin 28B in the setting of response-guided treatment with detailed on-treatment virological monitoring

    Hepatology

    Volume 54, Issue 3, 2 September 2011, Pages: 772–780, Alessandra Mangia, Alexander J. Thompson, Rosanna Santoro, Valeria Piazzolla, Massimiliano Copetti, Nicola Minerva, Daniela Petruzzellis, Leonardo Mottola, Donato Bacca and John G. McHutchison

    Article first published online : 21 JUL 2011, DOI: 10.1002/hep.24458

  16. You have free access to this content
    Optimizing the treatment of chronic hepatitis due to hepatitis C virus genotypes 2 and 3: a review

    Liver International

    Volume 29, Issue s1, January 2009, Pages: 31–38, Giuseppe Tarantino and Antonio Craxì

    Article first published online : 21 JAN 2009, DOI: 10.1111/j.1478-3231.2008.01924.x

  17. Predictive value of rapid virological response and early virological response on sustained virological response in HCV patients treated with pegylated interferon α-2a and ribavirin

    Journal of Gastroenterology and Hepatology

    Volume 22, Issue 6, June 2007, Pages: 832–836, Jian-Wu Yu, Gui-Qiang Wang, Li-Jie Sun, Xiao-Guang Li and Shu-Chen Li

    Article first published online : 21 MAR 2007, DOI: 10.1111/j.1440-1746.2007.04904.x

  18. You have free access to this content
    Early identification of HCV genotype 1 patients responding to 24 weeks peginterferon α-2a (40 kd)/ribavirin therapy

    Hepatology

    Volume 43, Issue 5, May 2006, Pages: 954–960, Donald M. Jensen, Timothy R. Morgan, Patrick Marcellin, Paul J. Pockros, K. Rajender Reddy, Stephanos J. Hadziyannis, Peter Ferenci, Andrew M. Ackrill and Bernard Willems

    Article first published online : 20 APR 2006, DOI: 10.1002/hep.21159

  19. You have free access to this content
    Diagnosis, management, and treatment of hepatitis C: An update

    Hepatology

    Volume 49, Issue 4, April 2009, Pages: 1335–1374, Marc G. Ghany, Doris B. Strader, David L. Thomas and Leonard B. Seeff

    Article first published online : 2 DEC 2008, DOI: 10.1002/hep.22759

  20. You have free access to this content
    Pegylated interferon alfa and ribavirin for 14 versus 24 weeks in patients with hepatitis C virus genotype 2 or 3 and rapid virological response

    Hepatology

    Volume 47, Issue 1, January 2008, Pages: 35–42, Olav Dalgard, Kristian Bjøro, Helmer Ring-Larsen, Einar Bjornsson, Mona Holberg-Petersen, Eva Skovlund, Olle Reichard, Bjørn Myrvang, Bo Sundelöf, Ståle Ritland, Kjell Hellum, Aril Frydén, Jon Florholmen and Hans Verbaan

    Article first published online : 1 NOV 2007, DOI: 10.1002/hep.21975